&bgr;3-adrenergic receptor agonist crystal forms, processes...
&bgr;3-adrenoreceptor agonists, agonist compositions and...
&bgr;3-adrenoreceptor agonists, agonist compositions and...
&Dgr;2-1,2,3-TRIAZOLINE ANTICONVULSANTS AND THEIR ACTIVE...
[(Indol-3-yl)-cycloalkyl]-3-substituted azetidines...
[1,2,3]-triazolo[4,5-d] pyrimidine...
[1,2,4]triazolo[1,5-c]pyrimidine...
[1-indanon-2-yl]methylpiperidines
[2-substituted-5-[3-thienyl)-benzyl]-2-...
[3-(C5-14ALKYL-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLIN-6-YL)-...
[5-CHLORO-6-PHENYL-2-(4-TRIFLUOROMETHYLPHENYL)-4-PYRIMI...
−E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethylpiperid...
&OHgr;-amino-&agr;-hydroxycarboxylic acid derivatives having...
&OHgr;-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as...
&ohgr;-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as...
( S...
(−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0&rsq...
(−)-mefloquine to block puringergic receptors and to...
(+) naloxone and epinephrine combination therapy
(+)-Hydroxyrisperidone compositions and methods